← Back to Dihexa

VS Peps · Certificate № JN-260602-2848

Certificate of Analysis

Compound identity

DHX

Dihexa

Angiotensin IV derivative · 15mg lyophilized

Batch identifiers

Batch IDJN-260602-2848
Lab referenceLR-08416
Test date2026-06-02
Format15mg · lyophilized

HPLC Analysis

High-Performance Liquid Chromatography

Reported purity

98.5%

Area under the target peak as a percentage of total area.

Batch · 2026-06-02Janoshik Analytical · HPLC
98.5%DHX2 MIN5 MIN8 MIN12 MIN

Identity verification

Compound nameDihexa
Editorial codeDHX
Molecular formConfirmed by MS
Test methodRP-HPLC / UV-Vis
Reference standardIn-house standard, characterized
Storage at testLyophilized, sealed vial, RT

Structure

Non-peptide structure
3-letter notation

Modifications

  • 01N-hexanoyl-Tyr-Ile + 6-aminohexanoic amide (Angiotensin IV derivative)

Sourcing & storage

Sourcing chain

Manufactured in a GMP-audited facility (cGMP-compliant)

Storage & handling

Lyophilized: stable at room temperature in original sealed vial. Reconstituted: refrigerate at 2–8°C and use within 21 days. Research use only.

Lab analyst signature

Janoshik Analytical

Verified · 2026-06-02

Document control

Certificate № JN-260602-2848Issued 2026-06-02Format RP-HPLC / UVDistribution Per-product page

Research use only. This certificate documents analytical results for the batch identified above. Products are sold strictly for laboratory and research applications and are not intended for human or animal consumption, diagnosis, treatment, or prevention of any disease. The information herein is provided in good faith based on third-party HPLC analysis but is not a guarantee or warranty. See Research Use Disclaimer for full terms.